Weight-loss drug before frozen embryo transfer in obese women
Part of Hormones & metabolism clinical trials.
This trial tests a once-weekly injection that helps with weight loss and may improve the chances of a successful frozen embryo transfer in women with obesity. It aims to see if losing weight before the transfer leads to better pregnancy outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 20 and 40 years old.
- Your body mass index (BMI) is 28 or higher.
- You are planning to have a frozen embryo transfer.
- You have at least one frozen embryo available for transfer.
- You have not had weight-loss surgery in the past or plan to have it during the trial.
- You do not have any medical condition that would make the trial unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the weight-loss drug tirzepatide can help people with obesity-related endometrial cancer before their hysterectomy. It may improve surgical outcomes and overall health.
This study tests a medication called tirzepatide (a daily injection) to help people who haven't lost enough weight after weight-loss surgery. If you fit the criteria, the medication may help you lose more weight healthily.
This study tests a medicine called tirzepatide to see if it helps people with overweight or obesity lose weight, whether or not they also have type 2 diabetes. Tirzepatide is given as an injection and works on hormones that control appetite.
This study tests a weekly injection called tirzepatide to help people with obesity lose weight. It will be done at Hospital de Clínicas in Paraguay and lasts about 12 months.
This trial tests a once-weekly injection (tirzepatide) versus a placebo to help people who are obese or overweight with related health conditions lose weight. You may qualify if you have tried to lose weight through diet before, but have not been successful.
This study tests whether tirzepatide, a medication that helps with weight loss and blood sugar control, can improve the ability to exercise and daily function in people who have heart failure with reduced pumping strength and are overweight or obese.
Hear when a new Tirzepatide trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.